|
End-of-day quote
Bulgaria S.E.
24/08/2026
|
5-day change | 1st Jan Change | ||
| 2.080 EUR | +0.48% |
|
+7.49% | +46.01% |
| 22/07 | Sopharma AD Reports Sales Results for the First Half 2026 | CI |
| 29/06 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| Market Cap | 213.54Cr 128.25Cr 109.91Cr 102.83Cr 94Cr 177.4Cr 12TCr 179.29Cr 1.22TCr 473.12Cr 6.17TCr 481.56Cr 471.13Cr 20TCr | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 267.67Cr 160.76Cr 137.77Cr 128.89Cr 117.84Cr 222.37Cr 15TCr 224.73Cr 1.53TCr 593.04Cr 7.73TCr 603.62Cr 590.55Cr 26TCr | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 day | +0.48% | ||
| 1 week | +7.49% | ||
| Current month | +8.05% | ||
| 1 month | +9.47% | ||
| 3 months | +11.83% | ||
| 6 months | +11.23% | ||
| Current year | +46.01% |
| 1 week | 1.92 |  | 2.1 |
| 1 month | 1.87 | | 2.1 |
| Current year | 1.41 | | 2.1 |
| 1 year | 1.26 | | 2.1 |
| 3 years | 0.94 | | 2.1 |
| 5 years | 0.58 | | 2.1 |
| 10 years | 0.41 | | 2.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | +7.49% | +66.70% | +113.36% | 128.25Cr | |
| -0.38% | -3.43% | -42.67% | -14.72% | 1.52TCr | |
| +0.64% | -2.92% | -44.66% | -30.55% | 647.72Cr | |
| +1.12% | +5.01% | -15.11% | -9.64% | 638.49Cr | |
| -1.17% | -1.46% | -3.63% | -24.10% | 426.49Cr | |
| +0.32% | +0.81% | -18.19% | -39.20% | 324.59Cr | |
| -3.91% | -3.99% | -48.00% | -28.16% | 293.44Cr | |
| -1.70% | -2.31% | +0.40% | -34.91% | 294.07Cr | |
| +0.23% | -3.92% | -15.76% | -5.88% | 254.94Cr | |
| -0.61% | -0.79% | +46.18% | - | 238.8Cr | |
| Average | -0.50% | -0.85% | -7.47% | -8.20% | 476.58Cr | |
| Weighted average by Cap. | -0.32% | -1.99% | -22.92% | -16.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 213.95Cr 128.5Cr 110.12Cr 103.02Cr 94Cr 177.74Cr 12TCr 179.63Cr 1.22TCr 474.01Cr 6.18TCr 482.47Cr 472.02Cr 20TCr | 263.27Cr 158.12Cr 135.51Cr 126.77Cr 115.9Cr 218.71Cr 15TCr 221.03Cr 1.5TCr 583.28Cr 7.6TCr 593.69Cr 580.83Cr 25TCr |
| Net income | 7.78Cr 4.68Cr 4.01Cr 3.75Cr 3.43Cr 6.47Cr 447.68Cr 6.54Cr 44Cr 17Cr 224.8Cr 18Cr 17Cr 743.78Cr | 13Cr 8.02Cr 6.87Cr 6.43Cr 5.88Cr 11Cr 767.87Cr 11Cr 76Cr 30Cr 385.58Cr 30Cr 29Cr 1.28TCr |
| Net Debt | 44Cr 27Cr 23Cr 21Cr 20Cr 37Cr 2.55TCr 37Cr 253.09Cr 98Cr 1.28TCr 100.17Cr 98Cr 4.24TCr | 54Cr 33Cr 28Cr 26Cr 24Cr 45Cr 3.11TCr 45Cr 308.41Cr 119.92Cr 1.56TCr 122.06Cr 119.42Cr 5.17TCr |
Employees
6,005
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | €2.080 | +0.48% | 48,459 |
| 21/26/21 | €2.070 | +5.88% | 55,721 |
| 20/26/20 | €1.955 | +0.77% | 47,919 |
| 19/26/19 | €1.940 | +0.52% | 52,644 |
| 18/26/18 | €1.930 | -0.26% | 6,386 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
